Careplus Group CPG MK Sector: Rubber Products
|
|
- Noah Greene
- 5 years ago
- Views:
Transcription
1 An emerging force Careplus is an emerging small-sized rubber-gloves manufacturer with an ambitious expansion plan. The company has doubled its capacity to 4bn units in the past 4 years and set its target on reaching the 1bn capacity mark by 22. Earnings were weak in 216, but have rebounded in 1Q17, driven by higher sales demand and improved efficiencies. Management is confident about delivering better earnings ahead in tandem with its capacity expansion, rising nitrile mix and improving efficiencies. Targets a 25% CAGR in capacity over 216-2E With an ambitious expansion plan in full swing, Careplus aims to hit a capacity target of 1bn gloves by 22E, implying a 25% CAGR over 216-2E. In tandem with market demand, Careplus is also aiming to ramp up its nitrile gloves production from 15% currently, to over 3% of its total product mix by 22E. A higher nitrile mix generally leads to better margin compared to latex gloves on lower raw material consumption and higher production efficiency. Global rubber-gloves demand remains robust, and is expected to grow by 6-8% annually, which should sustain Careplus utilisation level in the 7-8% range. Competition within the industry has also moderated with key players slowing expansion, allowing for better pricing management and to the benefit smaller players like Careplus. Have earnings troughed in 216? Earnings were down sharply in 216, but showed a good rebound in 1Q17 underpinned by capacity expansion, improved efficiency and a favourable product mix. Natural rubber prices, a key raw material, have gradually trended down from a peak of RM8/kg to below RM6/kg now. Against the backdrop of strong capacity expansion, favourable industry dynamics, rising nitrile contribution and moderating raw material prices, management is confident about brighter days ahead for Careplus. Share price has rebounded significantly Careplus share price has been up sharply since the release of the 1Q17 results. The share price spiked from 29.5sen to a high of 43.5sen, before retreating to its last close of 4.5sen. Valuation-wise, Careplus shares trade at 64x trailing-12 months earnings. However, assuming the 1Q17 run rate were to carry through for the full year, the shares would be trading at approximately a 13x PER for 217E. The sector average PER in our glove universe stands at ca.21x for CY17E and 18x for CY18E, but we note that all 4 companies under our coverage have a much larger production capacity and stronger track record of earnings delivery. Earnings & Valuation Summary FYE 31 Dec (RMm) 213 (1) 213 (2) Revenue EBITDA Pretax profit Net profit EPS (sen) PER (x) Core net profit Core EPS (sen) Core EPS growth (%) 4. (52.8) (97.3) Core PER (x) Net DPS (sen) Dividend Yield (%) EV/EBITDA (x) Company Note Careplus Group CPG MK Sector: Rubber Products 6 July 217 Not rated Upside: n/a Price Target: N/A Previous Target: N/A (RM) Jun-14 Oct-14 Feb-15 Jun-15 Oct-15 Feb-16 Jun-16 Oct-16 Feb-17 Jun-17 Price Performance 1M 3M 12M Absolute.% +3.6% +2.9% Rel to KLCI +1.3% +28.6% +12.9% Stock Data Issued shares (m) Mkt cap (RMm)/(US$m) 195.7/45.5 Avg daily vol - 6mth (m) wk range (RM) Est free float 41.7% BV per share (RM).2 P/BV (x) 2.2 Net cash/ (debt) (RMm) (16.2) ROE (216A).2% Derivatives No Shariah Compliant Yes Key Shareholders Kwee Shyan Lim 2.8% Thinking Cap Sdn Bhd 11.8% Ng Shu Si Source: Affin Hwang, Bloomberg 6.% Loh Jia Ying (63) jiaying.loh@affinhwang.com Chg in EPS (%) Affin/Consensus (x) , Bloomberg Notes: (1) For the 12-month period January 212 to January 213, prior to the change of year-end from January to December (2) For the 11-month period of February 213 to December 213, as a result of the change of year-end from January to December Page 1 of 8
2 2 years of glove-manufacturing experience Careplus was listed on the ACE Market of Bursa Securities in 21 with a niche focus on latex gloves backed by over 2 years of experience in the glove business. With a total annual production capacity of 3.9bn gloves, Careplus is a relatively small player within the glove manufacturing space, where the four incumbents, ie Top Glove (TOPG MK, RM5.8, BUY), Hartalega (HART MK, RM6.87, BUY), Kossan (KRI MK, RM6.6, HOLD) and Supermax (SUCB MK, RM1.96, HOLD) control more than half of the global gloves production. Fig 1: Capacity comparison against major glove manufacturers Company Annual capacity Top Glove 48bn Hartalega 24bn Kossan 22bn Supermax 22bn Careplus 4bn Source: Affin Hwang, Companies Fig 2: Careplus capacity breakdown Subsidiary Types Annual capacity Remarks Rubbercare Products Factory 1 Latex gloves.42bn 1% owned Factory 2 Warehouse Careglove Global Factory 3 Latex & nitrile gloves 2.16bn 5% + 1 share (JV with Descarpack) Careplus (M) Factory 4 Latex & nitrile gloves 1.32bn 1% owned Total 3.9bn Source: Affin Hwang, Company OEM and OBM manufacturer Careplus runs on a hybrid OEM and OBM business model, but still predominantly manufactures more OEM gloves. It has an in-house brand Rubbercare, which distributes both nitrile and latex gloves, but is comparatively smaller than its OEM mix. Careplus also has a joint venture business with Descarpack Descartaveis do Brasil Ltda (Descarpack), in which both jointly own Careglove Global. Careplus runs 3 factories situated within close vicinity to each other in Negeri Sembilan (Malaysia) with one warehouse designated for raw material and inventory management. JV partner for Brazilian exposure Descarpack came into the picture in 211, where it formed a JV business with Careplus under Careglove Global. Prior to the JV, we understand that Descarpack was a long-time business customer with a good and cordial relationship. As part of the JV agreement, Careplus agrees to lend its glove manufacturing expertise while Descarpack plans to commit to certain manufacturing volumes for its onward distribution into Brazil, where it has a strong foothold and wide distribution network. Careglove Global is a highly profitable subsidiary, but its joint ownership means significant profit dilution at the PATAMI level, as evident in the high minority interest charge. Page 2 of 8
3 Fig 3: Corporate milestones of Careplus Increasing nitrile contribution Recognising the structural shift for nitrile gloves demand, Careplus began the production for synthetic rubber gloves beginning in 216. Although a latecomer to the game, it has continuously ramped up its nitrile capacity, leading to 15% in production mix currently, compared to just 9% in 215. Careplus also manufactures surgical gloves, although volume is minimal due to the niche nature of demand. With future expansion in mind, Careplus plans to focus more on nitrile expansion (target nitrile mix of 3% by 22E) in line with market demand, which could lead to better margins moving forward. Fig 4: Careplus product mix in 215 Fig 5: Careplus product mix in 216 Surgical 1% Surgical 1% Nitrile 9% Nitrile 14% Latex 9% Latex 85% Single region concentration risk The Central and South America market dominates Careplus sales mix, which does present significant concentration risk. This risk would be hard to mitigate, considering more than half of its existing capacity from Careglove Global is dedicated for Descarpack. Careplus management is cognisant of this and has taken a proactive approach to diversify by growing other markets, as well as boosting expansion at its Careplus (M) subsidiary. Apart from Central and South America, Careplus has a presence in other Asia Pacific markets, understandably due to its heavy latex gloves mix, which is generally the preferred and cheaper option for developing regions. Page 3 of 8
4 Fig 6: Careplus geographical mix in 215 Fig 7: Careplus geographical mix in 216 Others 2% Others 3% North America 8% Malaysia 1% Other Asia Pacific 18% Central and South America 71% North America 5% Malaysia 2% Other Asia Pacific 2% Central and South America 7% Commendable capacity expansion track record As per any manufacturing business, growing capacity and keeping costs in check are the two core business pillars, apart from ongoing innovation and process improvements. Careplus has a commendable capacity expansion track record, as it grew from.42bn in glove capacity from a single factory at its IPO in 21 to the current total annual capacity of 3.9bn gloves across three factories, over a six-year period. Utilisation remains firmly above the 7% region for the past four years, although it did trough at 67% in 216, but nonetheless still is a respectable utilisation rate. Volume has been growing healthily over the past few years, owing to stronger sales penetration and higher product uptake from its JV partner. Moving forward, robust global rubber gloves demand, which is expected to grow by 6-8% annually based on the company, should sustain Careplus s utilisation level at the 7-8% level, according to management. Fig 8: Careplus historical production capacity and output m pcs 4,5 4, 9% Production capacity Production output Utilisation 88% 3,9 1% 9% 3,5 3, 2,5 2, 1,5 1, 1,752 1,577 72% 2,46 2,46 1,778 2,174 67% 2,617 8% 7% 6% 5% 4% 3% 2% 5 1% % Plans to grow capacity to 1bn gloves by 22 As part of its capacity expansion plan, Careplus has put in place strategy to grow its capacity by more than two fold to 1bn gloves by 22, capitalising on the robust demand for rubber gloves. The bulk of the expansion will be focused on its wholly-owned subsidiary Careplus (M) or Factory 4. Currently, Careplus is constructing an additional block in Factory 4 that is expected to be completed by end-217. According to management guidance, production capacity could grow by over 3% to 5.16bn gloves by end 217 on the commissioning of new lines. Page 4 of 8
5 Fig 9: Planned capacity growth m pcs Production capacity Production output 1, 9, 8, 7, 6, 5, 4, 3, 2, 1, 5,16 3,96 6,6 5,4 8,4 6,888 9,48 8, E 218E 219E 22E (management guidance for 217-2E) Bottom-line track record has been more erratic though While sales have grown alongside the capacity increase, Careplus s bottom line has yet to exhibit similar growth qualities. This was largely due to production inefficiencies, recurring start-up losses, higher commissioning costs for new production lines, on top of the increase in raw-material prices and utility rates (ie, predominantly natural gas). Despite registering 2% yoy in top-line growth to RM229m in 216, Careplus s PAT fell 97% to RM.2m on a combination of intense competition, poor pricing management and production inefficiencies. Fig 1: Margin compression on competition and lower efficiency RMm Revenue EBITDA Margin 25 16% % % % % 16% 14% 12% 1% 8% 6% 4% 2% % Turnaround in 1Q17 Things took a turn for the better in 1Q17, when Careplus reported RM3.7m in quarterly profit, which already eclipsed the dismal performance for the whole of 216. Higher sales growth from the commissioning of new production lines led to better earnings, which were amplified by the effects of operating leverage. Our recent meeting with the CEO Mr Lim Kwee Shyan suggests cautious optimism in earnings delivery amid ongoing capacity expansion. If the company is successful in its capacity expansion efforts without incurring significant start-up costs, Careplus could be able to sustain similar levels of bottom line for the rest of the year. On top of that, raw material prices have dropped significantly, which generally benefits latex-focused glove manufacturers like Careplus. Page 5 of 8
6 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 1QFY14 2QFY14 3QFY14 4QFY14 1QFY15 2QFY15 3QFY15 4QFY15 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 7 July 217 Fig 11: Quarterly revenue has been growing RMm Revenue Revenue growth yoy % 1 9% % 8% 8 69% 69 7% % % % 4% 4 28% 3% % 2% 18% 2% 15% 1 1% 1% % Fig 12: EBITDA is rebounding off a low in 3Q16 RMm EBITDA EBITDA margin % 14 25% 12 21% 2% 1 19% 18% 16% 16% 8 14% 13% 14% 15% 13% 12% 13% 6 1% 9% 4 8% 5% %, Affin Hwang, Affin Hwang Have earnings troughed in 216? After a dismal performance in 216 (including one loss-making quarter), earnings staged a sharp rebound in 1Q17. Key factors that caused the earnings contraction such as higher-than-expected start-up losses, low production efficiency and higher raw material costs have slowly dissipated in 1H17. Natural rubber prices, a key raw-material input, have gradually trended down from a peak of RM8/kg to below RM6/kg now. With strong capacity expansion to underpin earnings, there is potential for margin expansion given the increasing nitrile contribution in its product mix, as well as benefits from economies of scale. Against the backdrop of strong capacity expansion, favourable industry dynamics, rising nitrile contribution and moderating raw material prices, Careplus management is confident about seeing brighter days ahead. Share price has rebounded significantly Careplus share price has been up sharply since the release of the 1Q17 results. We note the share price spiked from 29.5sen to a high of 43.5sen, before retreating to last close of 4.5sen. Valuation-wise, Careplus shares trade at a 64x PER based on earnings for the trailing-12-month period. However, assuming the 1Q17 run rate were to carry through for the full year, the shares would be trading at approximately a 13x PER for 217E. The sector average PER for our glove universe stands at approximately 21x for CY17E and 18x for CY18E, and we note that all four of the companies in our universe have much larger production capacity as well as a stronger track record of delivering on earnings. Fig 13: Peer comparison Stock Rating Price TP Mkt Cap Core PE (x) Core EPS Growth (%) P/BV ROE (%) DY (%) (RM) (RM) (RMm) CY17E CY18E CY17E CY18E CY17E CY17E CY18E FY17E FY18E HARTALEGA BUY , KOSSAN HOLD , SUPERMAX HOLD , (2.8) TOP GLOVE BUY , Sector average Source: Bloomberg, Affin Hwang forecasts; prices as of close on 6 July 217 Page 6 of 8
7 Careplus FINANCIAL SUMMARY Profit & Loss Statement Key Financial Ratios and Margins FYE 31 Dec (RMm) 213A (1) 213A (2) 214A 215A 216A FYE 31 Dec (RMm) 213A (1) 213A (2) 214A 215A 216A Revenue Growth Operating expenses (88.) (127.9) (132.) (16.2) (23.1) Revenue (%) EBITDA EBITDA (%) (4,184.6) (12.4) Depreciation (4.6) (6.9) (7.6) (11.6) (15.1) Core net profit (%) 54.6 (52.7) (96.8) EBIT Net interest income/(expense (1.2) (2.5) (2.7) (3.4) (4.7) Profitability Associates' contribution EBITDA margin (%) EI PBT margin (%) Pretax profit Net profit margin (%) Tax (.5) (.4) (.7) (.5) 1.9 Effective tax rate (%) (36.6) Minority interest.7 (1.3) (3.6) (6.6) (6.9) ROA (%) Net profit Core ROE (%) ROCE (%) Balance Sheet Statement Dividend payout ratio (%) FYE 31 Dec (RMm) 213A (1) 213A (2) 214A 215A 216A PPE Liquidity Other non-current assets Current ratio (x) Total non-current assets Op. cash flow (RMm) (4.6) (.4) Cash and equivalents Free cashflow (RMm) (22.4) (14.1) 2.2 (14.4) (26.5) Inventory FCF/share (sen) (6.4) (4.).6 (4.) (6.2) Trade receivables Other current assets Asset management Total current assets Inventory turnover (days) Trade payables Receivables turnover (day Short term borrowings Payables turnover (days) Other current liabilities Total current liabilities Capital structure Long term borrowings Net Gearing (x) Other long term liabilities Interest Cover (x) Total long term liabilities Quarterly Profit & Loss Shareholders' Funds FYE 31 Dec (RMm) 1QFY16 2QFY16 3QFY16 4QFY16 1QFY17 Revenue Cash Flow Statement Op costs (4.3) (46.6) (53.1) (61.3) (75.4) FYE 31 Dec (RMm) 213A (1) 213A (2) 214A 215A 216A EBITDA PAT Depn and amort (3.5) (4.) (4.3) (5.2) (2.6) Depreciation & amortisation EBIT Working capital changes (13.8) (1.8) (6.8) (8.9) (22.) Net int income/(exp) (2.9) (.7) (1.6) (.9) (2.7) Others EI Cashflow from operations (4.6) (.4) Inc from associates Capex (17.8) (13.7) (17.6) (32.1) (3.7) Pretax profit (1.4) Others Tax (.3) (.3) (.1) 2.6 (.2) Cash flow from investing (17.5) (13.6) (17.5) (31.4) (3.4) MI (1.4) (1.6) (1.) (2.8) (2.4) Debt raised/(repaid) (2.8) Net profit.7.1 (2.4) Equity raised/(repaid) Core net profit.7.1 (2.4) Dividends paid - (.6) - (.6) (1.2) Others (2.9) (2.1) Margins (%) Cash flow from financing (2.9) EBITDA Free Cash Flow (22.4) (14.1) 2.2 (14.4) (26.5) PBT (2.4) PAT (4.2) Notes: (1) For the 12 month period January 212 to January 213, prior to the change of year-end from January to December (2) For the 11-month period of February 213 to December 213, as a result of the change of year-end from January to December Page 7 of 8
8 Equity Rating Structure and Definitions BUY Total return is expected to exceed +1% over a 12-month period HOLD Total return is expected to be between -5% and +1% over a 12-month period SELL Total return is expected to be below -5% over a 12-month period NOT RATED Affin Hwang Investment Bank Berhad does not provide research coverage or rating for this company. Report is intended as information only and not as a recommendation The total expected return is defined as the percentage upside/downside to our target price plus the net dividend yield over the next 12 months. OVERWEIGHT Industry, as defined by the analyst s coverage universe, is expected to outperform the KLCI benchmark over the next 12 months NEUTRAL Industry, as defined by the analyst s coverage universe, is expected to perform inline with the KLCI benchmark over the next 12 months UNDERWEIGHT Industry, as defined by the analyst s coverage universe is expected to under-perform the KLCI benchmark over the next 12 months This report is intended for information purposes only and has been prepared by Affin Hwang Investment Bank Berhad (14389-U) ( the Company ) based on sources believed to be reliable. However, such sources have not been independently verified by the Company, and as such the Company does not give any guarantee, representation or warranty (express or implied) as to the adequacy, accuracy, reliability or completeness of the information and/or opinion provided or rendered in this report. Facts, information, views and/or opinion presented in this report have not been reviewed by, may not reflect information known to, and may present a differing view expressed by other business units within the Company, including investment banking personnel. Reports issued by the Company, are prepared in accordance with the Company s policies for managing conflicts of interest arising as a result of publication and distribution of investment research reports. Under no circumstances shall the Company, its associates and/or any person related to it be liable in any manner whatsoever for any consequences (including but are not limited to any direct, indirect or consequential losses, loss of profit and damages) arising from the use of or reliance on the information and/or opinion provided or rendered in this report. Any opinions or estimates in this report are that of the Company, as of this date and subject to change without prior notice. Under no circumstances shall this report be construed as an offer to sell or a solicitation of an offer to buy any securities. The Company and/or any of its directors and/or employees may have an interest in the securities mentioned therein. The Company may also make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report. Comments and recommendations stated here rely on the individual opinions of the ones providing these comments and recommendations. These opinions may not fit to your financial status, risk and return preferences and hence an independent evaluation is essential. Investors are advised to independently evaluate particular investments and strategies and to seek independent financial, legal and other advice on the information and/or opinion contained in this report before investing or participating in any of the securities or investment strategies or transactions discussed in this report. Third-party data providers make no warranties or representations of any kind relating to the accuracy, completeness, or timeliness of the data they provide and shall not have liability for any damages of any kind relating to such data. The Company s research, or any portion thereof may not be reprinted, sold or redistributed without the consent of the Company. The Company, is a participant of the Capital Market Development Fund-Bursa Research Scheme, and will receive compensation for the participation. This report is printed and published by: Affin Hwang Investment Bank Berhad (14389-U) A Participating Organisation of Bursa Malaysia Securities Berhad 22nd Floor, Menara Boustead, 69, Jalan Raja Chulan, 52 Kuala Lumpur, Malaysia. T : F : research@affinhwang.com Page 8 of 8
MMC MMC MK Sector: Utilities
Weakness continues into 2Q MMC reported a lacklustre set of earnings for 1H17, as PATAMI of RM118m (-3 yoy) was below expectations. 1H17 results constituted 22% of our and consensus full year forecast.
More informationSime Darby SIME MK Sector: Plantation
A good end to the year Sime Darby s (SIME) FY17 core net profit of RM2.69bn (+1.4% yoy) came in above expectations. The variance was mainly due to higherthan-expected contribution from the plantation and
More informationSime Darby SIME MK Sector: Plantation
9MFY17 results below expectations SIME s 9MFY17 core net profit of RM1.58bn (+64.2% yoy) came in below expectations. The variance was mainly due to a lower-thanexpected contribution from the property and
More informationStar Media STAR MK Sector: Media
Print remains under pressure We expect prospects for the print media industry to remain weak in 2016 given the challenging market environment, poor consumer sentiment as well as the structurally declining
More informationUchi Tech UCHI MK Sector: Technology
Still all about its yields Uchi s stock price has righfully re-rated over the past 2 years on its attractive valuations and above-average dividend yields. While the latter remains attractive at just under
More informationBumi Armada BAB MK Sector: Oil & Gas
Clearer skies from here on BAB reported a 2Q17 revenue of RM694.4m (+71.8% qoq, +72.4% yoy) and headline profit of RM116.6m (+142.3% qoq, +122.5% yoy). After adjusting for the one-offs (big-ticket items
More informationSupermax. Rubber Gloves. Company Update. Bouncing back in BUY (maintain) Price Target: RM2.60 ( ) 26 January 2012
Rubber Gloves 26 January 2012 PP 10251/07/2012(030525) Company Update Supermax SUCB MK RM2.20 BUY (maintain) Bouncing back in 2012 Bright skies ahead We recently visited Supermax to get an update on the
More informationIHH Healthcare IHH MK Sector: Healthcare & Pharmaceuticals
Inpatient admissions accelerated in 1Q16 Core net profit grew by a tepid 5% yoy in 1Q16, but we deemed this in-line with expectations. Revenue and EBITDA grew by 24% yoy and 17% yoy in the quarter, driven
More informationTropicana TRCB MK Sector: Property
Disposal of 251 acres of land in Johor We are positive on Tropicana s announcement to dispose 251.6 acres of freehold land in Gelang Patah, as this will reduce its exposure in Johor, as well as lock in
More informationIOI Corp IOI MK Sector: Plantation
Waiting IOI has made its submissions and is awaiting an official reply from the RSPO Complaint Panel on its application to lift the certification suspension. We believe the decline in market capitalisation
More informationUOA Development UOAD MK Sector: Property
Dividend play In 2016, UOA has thus far launched two projects and plans to launch a third development this year. The total estimated gross development value (GDV) of these three projects is RM3.2bn. Unbilled
More informationPetra Energy PENB MK Sector: Oil & Gas
Small hiccup, turnaround remains in motion Petra Energy (PENB) remains a strong contender to win the upcoming modification, construction and maintenance (MCM) contract from Petronas, which is to be split
More informationTop Glove TOPG MK Sector: Rubber Products
7 June 2016 Speed bump Top Glove, a country top pick, is set to announce 3Q FY16 results next week. We project core net profit to be weaker qoq at RM8090m, on overall lower ASPs, higher raw material prices
More informationTa Ann TAH MK Sector: Timber
Plantation taking the lead We believe Ta Ann s plantation division is likely to take the lead in 2016. The rising FFB and CPO production coupled with better CPO prices should provide future earnings growth
More informationA nitrile glove price war looming ahead
Rubber Gloves April 1 PP 151/7/1(355) Sector Update NEUTRAL (downgrade) Absolute Performance (%) 1M 3M 1M Kossan -5. -.3 -. Supermax -.5-3. -1.7 Top Glove -. -1. -13.7 Hartalega -. +3. +3. Adventa -1.3-7.
More informationIOI Corp IOI MK Sector: Plantation
Focused on lifting of RSPO suspension IOI is focused on taking corrective actions for early lifting of the RSPO membership suspension. We believe a prolonged suspension will have significant impact on
More informationCIMB Group CIMB MK Sector: Banking
Indonesia a glimpse to better results ahead CIMB Niaga released a stronger set of results for 2Q16. We remain convinced that CIMB Group is on track for an earnings recovery and the Group s 2Q16 results
More informationTechnology. Focus: Optical sensing & Communication. Neutral (maintain) Sector Update
Focus: Optical sensing & Communication Our alliance partner, Daiwa, recently issued a thematic report on the Optical Sensing and Communication (OSC) sector, focusing on the sector s large market potential
More informationSunway Construction. BUY (maintain) Upside 28% 18 April Price Target: RM1.98 Previous Target: RM1.74. Company Update.
More to come Sunway Construction (Suncon) was awarded the RM1.2bn Klang Valley MRT Line 2 (MRT2) project on 29 March 2016. This lifts its order book to RM4.8bn, equivalent to 2.5x FY15 revenue, improving
More informationOCT NOV DEC JAN FEB MAR APR MAY JUN JUL AUG GENERAL
8 September ASEAN manufacturing PMI rose above 50 in August Indonesia inflation rate slowed slightly to 3.82% ASEAN purchasing managers index (PMI) rose above 50 level to 50.4 in August, after falling
More informationCIMB Group CIMB MK Sector: Banking
Group s outlook stabilizing We believe that the CIMB Group is on track for an earnings recovery subsequent to being bogged down with hefty provision costs from Indonesia as well as a restructuring and
More informationMalaysia- GDP & BOP 1Q17
Real GDP growth surprised on the upside in 1Q17 Real GDP growth rose by 5.6% in 1Q17, exceeding market expectations Malaysia s real GDP growth rose by 5.6% yoy in 1Q17 (4.5% in 4Q16), significantly higher
More informationSEP OCT NOV DEC JAN FEB MAR APR MAY JUN JUL GENERAL
4 August ASEAN manufacturing PMI fell below 50 in July Drop in Asean s manufacturing PMI may be due to seasonal factors IHS Markit s ASEAN Manufacturing Purchasing Managers Index (PMI) fell to 49.3 in
More informationMarket Access. Results Review 1Q FY17. M&A Securities. Hartalega Holdings Berhad. Record Sales with Lower Margins BUY (TP:RM4.
M&A Securities Results Review 1Q FY17 PP14767/09/2012(030761) Hartalega Holdings Berhad BUY (TP:RM4.78) Wednesday, August 03, 2016 Record Sales with Lower Margins Results Review Current Price (RM) New
More informationSunway Construction SCGB MK Sector: Construction
Building jobs replenishment; upgrading to Buy We upgrade Sunway Construction (Suncon) to BUY from Hold with an unchanged 12M TP of RM2.45, based on a 10% discount to RNAV. We believe Suncon is an apolitical
More informationHSS Engineers HSS MK Sector: Engineering Construction
Positive prospects HSS could secure more contracts like ECRL, Pan Borneo and HSR with its tender book of RM2-300m. We tweaked our FY17E earnings to reflect better timing in securing new contracts and progress
More informationJUL AUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN
BOT raised GDP growth forecasts for and 2018 BOT kept its policy rate unchanged at 1.5% for eighteen straight month Bank of Thailand (BOT) maintained its policy rate, i.e. one-day repurchase rate, at 1.5%
More informationGabungan AQRS AQRS MK Sector: Construction & Infra
Affordable housing focus We upgrade our call on Gabungan AQRS (GAQRS) to a BUY from Sell previously and revise up our target price (TP) to RM1.20 from RM0.70. We believe prospects for GAQRS to grow its
More informationResults Review. 3QFY13: Downsizing its workforce. Technology Bloomberg Ticker: UNI MK Bursa Code: November 2013
Results Review (Member of Alliance Bank group) PP7766/03/2013 (032116) 8 November 2013 Analyst Toh Woo Kim wookim@alliancefg.com +603 2604 3917 12-month upside potential Previous target price 0.89 Revised
More informationRubber Products. Waiting for the right grip. Neutral (maintain) Sector Update
Jan-15 Mar-15 May-15 Jul-15 Sep-15 Nov-15 Jan-16 Mar-16 May-16 Jul-16 Sep-16 Waiting for the right grip 2Q16 was another watershed quarter for the glove sector as earnings declined qoq largely due to ASP
More informationMEDIA PRIMA (HOLD, EPS )
MEDIA PRIMA (HOLD, EPS ) INDUSTRY: NEUTRAL EARNINGS EVALUATION 3Q results: Cost control lift earnings Results 9MFY13 core PATAMI grew by 11% to RM150.7m (13.81 sen/share), making up 75% and 70% of ours
More informationLafarge Malaysia LMC MK Sector: Building Materials
A tough year Weak domestic demand and oversupply of cement has put pressure on average selling prices (ASPs). Coupled with disappointing 2H16 results, the year looks gloomy for Lafarge. Profit margin is
More informationSEP OCT NOV DEC JAN FEB MAR APR MAY JUN GENERAL
IMF upgraded ASEAN GDP growth forecast for ASEAN economies to benefit from strong economic growth in China The International Monetary Fund (IMF) recently upgraded ASEAN GDP growth projection for in its
More informationMarket Access. Results Review 4Q FY16. M&A Securities. Hartalega HoldingsBerhad. Double-Digit Growth amid Challenging Times BUY (TP:RM4.
M&A Securities Results Review 4Q FY16 PP14767/09/2012(030761) Hartalega HoldingsBerhad BUY (TP:RM4.78) Wednesday, May 04, 2016 Double-Digit Growth amid Challenging Times Results Review Current Price (RM)
More informationRough Start. Results Note. Price: RM5.40 Target Price: RM4.95. By Desmond Chong l
UMW Holdings Rough Start By Desmond Chong l cwchong@kenanga.com.my 1Q16 core PATAMI of RM16.9m (>100% QoQ; -90% YoY) came in way below estimates, making up only 5% of both our and consensus estimates.
More informationSapura Energy SAPE MK Sector: Oil & Gas
Still cautious Despite the 76% decline in SAPE s share price over the past 12 months, we believe it is still too early to revisit the stock. Downside risks remain from potential impairment, negative earnings
More informationPharmaniaga MARKET PERFORM. 1Q15 Inline but Rich Valuations. Results Note. Price: RM6.91 Target Price: RM6.95. PP7004/02/2013(031762) Page 1 of 5
Pharmaniaga 1Q15 Inline but Rich Valuations By the Kenanga Research Team l research@kenanga.com.my Period 1Q15 Actual vs. Expectations 1Q15 PATAMI of RM31.8m (+21% YoY) came in at 32% and 31% of our and
More informationSupermax Corporation Berhad Super value on offer
PP 10745/05/2013/032438 19 July 2012 Initiating coverage Supermax Corporation Berhad Super value on offer BUY Target Price (TP): RM2.48 INVESTMENT HIGHLIGHTS World class latex glove producer. SUPERMAX
More informationGloves. In the pink of health. OVERWEIGHT (maintain) SECTOR UPDATE. 7 March 2014 KDN: PP 10251/07/2013 (032736)
Gloves OVERWEIGHT (maintain) Absolute Performance (%) 1M 3M 12M Kossan +7.3 +23.2 +180.9 Hartalega -4.2-6.4 +45.6 Supermax -3.4 +6.0 +52.6 Top Glove +7.1-3.7 +10.5 Source: Bloomberg Before After Rating
More informationSunway Berhad. OUTPERFORM Price: RM2.65 Target Price: RM3.08 KENANGA RESEARCH. Within expectations. Results Note KENANGA RESEARCH.
Results Note 02 December 2013 Sunway Berhad Within expectations Period 3Q13 / 9M13 Actual vs. Expectations Dividends None as expected. Key Results Highlights At 73% of our full-year FY13 estimates, the
More informationBermaz Auto Strong comeback
13 March 2018 3QFY18 Result Review Bermaz Auto Strong comeback INVESTMENT THESIS 3Q18 results in-line Earnings gapped up 82%qoq and 61%yoy MMSB volumes/earnings hit record high Re-affirm BUY at unchanged
More informationAUG SEP OCT NOV DEC JAN FEB MAR APR MAY JUN GENERAL
Bank Indonesia cut its reference rate by 25bps to 6.5% This was in tandem with slower global growth and Fed pause on rate Bank Indonesia (BI) unexpectedly cut BI reference rate by 25bps to 6.5% on the
More informationChin Hin CHIN MK Sector: Building Materials
Sustainability and expansion Chin Hin is the largest manufacturer of Autoclaved Aerated Concrete AAC blocks in Malaysia and management is expanding its manufacturing facilities and product range including
More informationTenaga Nasional New policy underpins rising dividend potential
13 December 2016 Corporate Update Tenaga Nasional New policy underpins rising dividend potential Maintain BUY Unchanged (TP): RM16.80 Tenaga announced a new dividend policy of a 30%-50% earnings payout
More informationMalaysia- Fiscal policy
Dec-14 Jan-15 Feb-15 Mar-15 Apr-15 May-15 Jun-15 Jul-15 Aug-15 Sep-15 Oct-15 Nov-15 Dec-15 Jan-16 Feb-16 Mar-16 Apr-16 May-16 Jun-16 Jul-16 22 July 2016 Higher oil prices may provide some fiscal flexibility
More informationSupermax Corporation Berhad OBM expenses pressuring on profit margin
06 November 2015 Initiate Coverage Supermax Corporation Berhad OBM expenses pressuring on profit margin Initiate with NEUTRAL Target Price (TP): RM2.09 INVESTMENT HIGHLIGHTS Pioneer of OBM gloves in Malaysia
More informationMarket Access. Briefing Notes. M&A Securities. BIMB Holdings Bhd BUY (TP:RM4.60) Shifting into High Gears
M&A Securities Briefing Notes PP14767/09/2012(030761) BIMB Holdings Bhd BUY (TP:RM4.60) Monday, October 12, 2015 Shifting into High Gears We attended post-1h15 results briefing organized by BIMB Holdings
More informationKossan Rubber Industries Berhad Higher dividend in the horizon
09 November 2012 Visit Note Kossan Rubber Industries Berhad Higher dividend in the horizon HIGHLIGHTS New plant focusing on surgical gloves production expected to commence operation in December 2012. Product
More informationMARKET PERFORM. FY15 Below Expectations. Results Note. Price: RM1.21 Target Price: RM1.39. By The Kenanga Research Team /
MRCB FY15 Below Expectations By The Kenanga Research Team / research@kenanga.com.my Period Actual vs. Expectations 4Q15/FY15 FY15 core net loss of RM74.7m was below market and our core net profit expectations
More informationMarket Access. M&A Securities. Results Review 1Q16. Malayan Banking Berhad. Hampered by Loan Loss. Monday, May 30, 2016 HOLD (TP: RM9.
M&A Securities Results Review 1Q16 PP14767/09/2012(030761) Malayan Banking Berhad Monday, May 30, 2016 HOLD (TP: RM9.10) Hampered by Loan Loss Results Review Actual vs. expectations. Malayan Banking Bhd
More informationPlantation. Inventory rises as production exceeds exports. NEUTRAL (maintain) Sector Update
12 September 217 Inventory rises as production exceeds exports CPO production in August decreased slightly mom on the back of lower production from the Peninsular and Sabah regions. Meanwhile, exports
More informationBermaz Auto Implications of Mazda s supply chain transplant
21 November 2016 Corporate Update Bermaz Auto Implications of Mazda s supply chain transplant INVESTMENT THESIS APM-Delta JV reflects Mazda s move to transplant its supply chain and transform its Malaysian
More informationCareplus Group Berhad FV: RM 0.29 Top Tier 2 Glove Player
ta securities holdings berhad(14948-m) A member of the ta group NEW LISTING Tuesday, November 23, 2010 Sector: Technology MENARA TA ONE, 22 JALAN P. RAMLEE, 50250 KUALA LUMPUR, MALAYSIA TEL: +603-20721277
More informationMarket Access. M&A Securities. Results Review 1Q15. Malayan Banking Bhd BUY (TP: RM10.70) Stabilizing Period. Results Review
M&A Securities Results Review 1Q15 PP14767/09/2012(030761) Malayan Banking Bhd BUY (TP: RM10.70) Friday, May 29, 2015 Stabilizing Period Results Review Actual vs. expectation. Malayan Banking Berhad (Maybank)
More informationMarket Access. Results Review (4Q16) M&A Securities. Scientex Berhad. Unstoppable Growth Amid Challenging Times. Tuesday, September 27, 2016
Market Access M&A Securities Results Review (4Q16) PP14767/04/2012(029 Tuesday, September 27, 2016 Scientex Berhad Unstoppable Growth Amid Challenging Times BUY (TP: RM8.33) Current Price (RM) New Target
More informationBelow Expectations. Results Note. Price: RM8.28 Target Price: RM6.73. By Desmond Chong l PP7004/02/2013(031762) Page 1 of 6
UMW Holdings Below Expectations By Desmond Chong l cwchong@kenanga.com.my Period 3Q15/9M15 Actual vs. Expectations Below expectations. The group reported 3Q15 normalised PATAMI of RM81.7m (+54% QoQ and
More informationSELL. Last Traded: RM6.75. Acquiring the World s Second Largest Surgical Glove Player
C O M P A N Y U P D A T E Monday, November 27, 2017 FBMKLCI: 1,717.23 Sector: Healthcare THIS REPORT IS STRICTLY FOR INTERNAL CIRCULATION ONLY* Top Glove Corporation Berhad TP: RM6.30 (-6.7%) Acquiring
More informationTenaga Nasional Bonus earnings not sustainable
29 January 2018 1QFY18 Results Review Tenaga Nasional Bonus earnings not sustainable 1QFY18 within estimates RP1 earnings inflated by favourable customer mix Bonus regulated earnings not sustainable in
More informationSyarikat Takaful Malaysia Berhad Ending on a high note
25 January 2017 4QFY16 Results Review Syarikat Takaful Malaysia Berhad Ending on a high note Maintain BUY Unchanged Target Price (TP): RM4.84 INVESTMENT HIGHLIGHTS Syarikat Takaful Malaysia Bhd (STMB)
More informationMarket Access. M&A Securities. Results Review 1Q15. BIMB Holdings Bhd BUY (TP:RM4.84) Brilliant Beginning. Results Review
M&A Securities Results Review 1Q15 PP14767/09/2012(030761) BIMB Holdings Bhd BUY (TP:RM4.84) Wednesday, May 27, 2015 Brilliant Beginning Results Review Actual vs. expectation. BIMB Holdings Berhad (BIMB)
More informationMarket Access. M&A Securities. Results Review 2Q15. Axiata Group Berhad. Satisfactory, Need to Push in 2H15. Friday, August 21, 2015 HOLD (TP:RM7.
M&A Securities Results Review 2Q15 PP14767/09/2012(030761) Axiata Group Berhad Friday, August 21, 2015 HOLD (TP:RM7.10) Satisfactory, Need to Push in 2H15 Results Review Actual vs. expectations. Axiata
More informationMarket Access. Company Note. M&A Securities. Nestle Malaysia Berhad. Steering Away From Turbulence. Tuesday, June 21, 2016 HOLD (TP: RM79.
M&A Securities Company Note PP14767/09/2012(030761) Nestle Malaysia Berhad Steering Away From Turbulence 1Q16 results review. To recap, Nestle Malaysia Berhad (Nestle) registered its 1Q16 revenue at RM1.3
More informationMarket Access. Results Review (1Q16) M&A Securities. Tan Chong Motor Holdings Bhd. Lacking the X-Factor SELL (TP: RM1.
M&A Securities Results Review (1Q16) PP14767/09/2012(030761) Tan Chong Motor Holdings Bhd Wednesday, May 11, 2016 SELL (TP: RM1.87) Lacking the X-Factor Results Review Actual vs. expectations. Tan Chong
More informationBURSA MALAYSIA BUY. Riding on sustained trading interest. Company report. (Maintained) Rationale for report: Company Result STOCK EXCHANGE
STOCK EXCHANGE BURSA MALAYSIA (BURSA MK, BMYS.KL) 22 October 22 Company report Cheryl Tan cheryltan@ambankgroup.com +63 236 2293 Riding on sustained trading interest Rationale for report: Company Result
More informationMarket Access. Results Review (3Q15) M&A Securities. Dutch Lady Milk Industries Berhad. Double Whammy. Wednesday, November 18, 2015 HOLD (TP: RM47.
Market Access M&A Securities Results Review (3Q15) PP14767/4/212(296 Dutch Lady Milk Industries Berhad Double Whammy Results Review Actual vs. expectations. Dutch Lady Milk Industries Berhad (Dutch Lady)
More informationSunway Construction. BUY (maintain) Upside 17%
Record revenue target Sunway Construction (SunCon) expects better performance in FY17 with a revenue target of RM2bn based on its current order book of RM4.8bn. It also targets to replenish its order book
More informationRubber Glove KENANGA RESEARCH NEUTRAL. Resilient sales volume growth in Sector Update KENANGA RESEARCH PP7004/02/2013(031762)
Sector Update 03 April 2013 Rubber Glove Resilient sales volume growth in 2012 NEUTRAL We maintain a Neutral rating on the rubber glove sector. According to Malaysian Rubber Export Promotion Council (MREPC)
More informationMarket Access. M&A Securities. Results Review (2Q16) SapuraKencana Petroleum Berhad. Solid Orderbook as a Shield BUY (TP: RM2.
M&A Securities Results Review (2Q16) PP14767/09/2012(030761) SapuraKencana Petroleum Berhad Thursday, September 17, 2015 BUY (TP: RM2.55) Solid Orderbook as a Shield Results Review Actual vs. expectations.
More informationBelow Expectations. Results Note. Price: RM6.95 Target Price: RM4.89. By Desmond Chong l PP7004/02/2013(031762) Page 1 of 5
UMW Holdings Below Expectations By Desmond Chong l cwchong@kenanga.com.my Period Actual vs. Expectations Dividends Key Result Highlights 4Q15 / FY15 Below expectations. The group reported 4Q15 normalised
More informationMalaysia. RCE Capital Results within; proposes bonus & rights. Hold (unchanged) Results Review 15 February 2012
PP16832/01/2013 (031128) Malaysia Results Review 15 February 2012 Hold (unchanged) Share price: Target price: RM0.515 Wong Chew Hann, CA wchewh@maybank-ib.com (603) 2297 8686 Stock Information RM0.45 (unchanged)
More informationSupermax Corporation Bhd
Equity Research Supermax Corporation Bhd 24 Aug 2010 KDN: PP10837/03/2011 (029371) BUY Current Price RM5.50 New Target Price RM6.80 Previous Target Price - Previous Recommendation - Upside To Target +23.6%
More informationStuck at Low Growth SELL. Last Traded: RM9.00. mn % 15.0% 10.0% 5.0% 0.0% -5.0% -10.0% Jan-15. Jul-16. Jul-17.
C O M P A N Y U P D A T E Wednesday, April 11, 218 FBMKLCI: 1,86.98 Sector: Transportation THIS REPORT IS STRICTLY FOR INTERNAL CIRCULATION ONLY* Malaysia Airports Holdings Berhad TP: RM8.61 (-4.3%) Stuck
More informationMarket Access. Briefing Notes. M&A Securities. Digi.Com Berhad. 4G is the Way Forward BUY (TP:RM6.10)
M&A Securities Briefing Notes PP14767/09/2012(030761) Digi.Com Berhad BUY (TP:RM6.10) Tuesday, September 08, 2015 4G is the Way Forward Digi hosted its Analyst s Day yesterday where the senior management
More informationSunway Bhd SWB MK Sector: Property
Two is greater than one We are positive on the proposed listing of Sunway Construction Group (SCG). We foresee keen investor demand for SCG shares in view of the positive construction sector outlook and
More informationMarket Access. Results Review 4Q15. M&A Securities. Digi.Com Berhad. Survives the Headwinds BUY (TP:RM5.90) Results Review
M&A Securities Results Review 4Q15 PP14767/09/2012(030761) Digi.Com Berhad BUY (TP:RM5.90) Wednesday, February 10, 2016 Results Review Survives the Headwinds Current Price (RM) New Fair Value (RM) Previous
More informationMarket Access. M&A Securities. Results Review 1Q15. Axiata Group Berhad. Slow in Recovery. Wednesday, May 20, 2015 HOLD (TP:RM7.
M&A Securities Results Review 1Q15 PP14767/09/2012(030761) Axiata Group Berhad Wednesday, May 20, 2015 HOLD (TP:RM7.40) Slow in Recovery Results Review Actual vs. expectations. Axiata Group Bhd (Axiata)
More informationA Weak Quarter. Results Note. Price: RM3.70 Target Price: RM3.70. By Sarah Lim l PP7004/02/2013(031762) Page 1 of 5
IJM Land Berhad A Weak Quarter By Sarah Lim l sarahlim@kenanga.com.my Period 3Q15/9M15 OUTPERFORM Share Price Performance Price: RM3.70 Target Price: RM3.70 Actual vs. Expectations Dividends Key Results
More informationMarket Access. Results Review 2Q16. M&A Securities. RHB Capital Berhad. Recovery in Decent Traction. Thursday, August 25, 2016 BUY (TP: RM5.
M&A Securities Results Review 2Q16 PP14767/09/2012(030761) RHB Capital Berhad BUY (TP: RM5.80) Thursday, August 25, 2016 Recovery in Decent Traction Results Review Actual vs. expectations. RHB Bank Berhad
More informationMarket Access. Results Review (4Q14) M&A Securities. Genting Plantations Berhad. Hit by Plantation-Malaysia Segment. Thursday, May 28, 2015
M&A Securities Results Review (4Q14) PP14767/09/2012(030761) Genting Plantations Berhad Thursday, May 28, 2015 HOLD (TP: RM10.77) Hit by Plantation-Malaysia Segment Results Review Actual vs. expectations.
More informationDismal 2Q15. Results Note. Price: RM8.49 Target Price: RM8.93. By Desmond Chong l PP7004/02/2013(031762) Page 1 of 6
UMW Holdings Dismal 2Q15 By Desmond Chong l cwchong@kenanga.com.my Period 2Q15/ 1H15 Actual vs. Expectations Below expectations. The group reported 2Q15 normalised PATAMI of RM70.4m (-60% QoQ and YoY),
More informationBloomberg Code: ATA IN
Auto OEM: 3-Wheelers Atul Feb Auto 03, 2015 Ltd India Research Stock Broking Bloomberg Code: ATA IN Stable quarter led by surge in exports volumes (TP revised ) : Operating revenue, EBITDA and PAT grew
More informationMarket Access. Results Review 1Q16. M&A Securities. Digi.Com Berhad. Equipped for Competition BUY (TP:RM5.75) Results Review
M&A Securities Results Review 1Q16 PP14767/09/2012(030761) Digi.Com Berhad BUY (TP:RM5.75) Monday, April 25, 2016 Equipped for Competition Results Review Actual vs. expectations. Digi.Com (Digi) started
More informationMarket Access. Results Review (1Q16) M&A Securities. Dayang Enterprise Holdings Bhd. A Quiet Quarter. Thursday, May 26, 2016 HOLD (TP: RM1.
M&A Securities Results Review (1Q16) PP14767/9/212(3761) Dayang Enterprise Holdings Bhd Thursday, May 26, 216 HOLD (TP: RM1.16) Results Review A Quiet Quarter Current Price (RM) New Target Price (RM) Previous
More informationGeorge Kent (M) Bhd Broadly Within
George Kent (M) Bhd Broadly Within 1Q19 C of RM18.9m came in broadly within expectations at 13% each of our/consensus estimates. No dividends declared, as expected. No changes to FY19-20E earnings. Upgrade
More informationPUBLIC INVESTMENT BANK
PUBLIC INVESTMENT BANK PublicInvest Research Results Review Thursday, November 26, 2015 KDN PP17686/03/2013(032117) PRESTARIANG Outperform DESCRIPTION An ICT service provider focusing on ICT training and
More informationAbove Expectations. Results Note. Price: RM1.69 Target Price: RM1.85. By Adrian Ng l
WCT Holdings Bhd Above Expectations By Adrian Ng l adrian.ng@kenanga.com.my 1Q16 core net profit (C) of RM32.0m came in above our but within consensus expectations accounting for 37% and 22% of estimates,
More informationMalaysian Resources Corp
Malaysian Resources Corp Sunnier Days By Adrian Ng l adrian.ng@kenanga.com.my FY17 CNP of RM101.2m came in above our, but below consensus, full-year estimates, at 130%/91%. Property sales of RM1.4b also
More informationPUBLIC INVESTMENT BANK
PUBLIC INVESTMENT BANK PublicInvest Research Results Review Wednesday, February 28, 2018 KDN PP17686/03/2013(032117) PRESTARIANG Outperform DESCRIPTION An ICT service provider focusing on ICT training
More informationAirAsia X Berhad. Maintain BUY. Showing its mettle
22 February 2018 4QFY17 Results Review AirAsia X Berhad Showing its mettle Maintain BUY Adjusted Target Price(TP): RM0.46 (from: RM0.43) INVESTMENT HIGHLIGHTS AAX earned commendable net profit of RM98.9m
More informationDRB-HICOM (BUY, EPS ) NEWSBREAK INDUSTRY: NEUTRAL
d DRB-HICOM (BUY, EPS ) NEWSBREAK INDUSTRY: NEUTRAL Acquiring Konsortium Logistic Highlights Comment Risks DRB has announced that its 100% owned KLAS has acquired 61.61% stake in Konsortium Logistic (KLB)
More informationMarket Access. M&A Securities. Results Review 3Q15. Telekom Malaysia Berhad. Hampered by Forex Translation Loss. Friday, November 27, 2015
M&A Securities Results Review 3Q15 PP14767/09/2012(030761) Telekom Malaysia Berhad Friday, November 27, 2015 HOLD (TP:RM6.87) Hampered by Forex Translation Loss Results Review Actual vs. expectation. Telekom
More informationCompany Update. Deleum Berhad. On the lookout for earnings surprises. Oil & Gas Bloomberg Ticker: DLUM MK Bursa Code: 5132.
Company Update (Member of Alliance Bank group) PP7766/03/2013 (032116) 3 May 2013 Analyst Arhnue Tan arhnue@alliancefg.com +603 2604 3909 12-month upside potential Target price 2.70 Current price (as at
More informationGraphite India BUY. Performance Highlights CMP. `93 Target Price `124. 4QFY2012 Result Update Capital Goods. Investment Period 12 Months
4QFY2012 Result Update Capital Goods May 11, 2012 Graphite India Performance Highlights Y/E March (` cr) 4QFY2012 3QFY2012 % chg (qoq) 4QFY2011 % chg (yoy) Net sales 452 437 3.5 304 48.6 EBITDA 83 90 (7.7)
More informationPRESTARIANG. (PRES MK EQUITY, PSTG.KL) 23 May UniMy closer to breakeven. Rationale for report: Company result Investment Highlights
Price Fair Value 52-week High/Low Key Changes Fair value EPS Company report Lavis Chong RM2.35 RM2.60 RM2.53/RM1.69 PRESTARIANG TECHNOLOGY (PRES MK EQUITY, PSTG.KL) 23 May 2017 UniMy closer to breakeven
More informationMaintain BUY Revised Target Price (TP): RM8.72 (previously RM8.18)
21 February 2018 4QFY17 Results Review Petronas Chemicals Group Berhad Strong earnings delivered as expected INVESTMENT HIGHLIGHTS Petronas Chemicals Group Bhd s (PChem) 4QFY17 earnings expanded by +1.8%yoy
More informationCompany Result 25 August 2017 Oriental Food Industries Holdings Berhad On a steady path
JF APEX SECURITIES BERHAD (47680-X) Company Result 25 August 2017 Oriental Food Industries Holdings Berhad On a steady path HOLD Maintained KLCI 1771 points Share Price RM1.61 Target Price RM1.61 Expected
More informationMarket Access. M&A Securities. Result Review (3Q16) Cahya Mata Sarawak Berhad. Loss-Making Business Turns Into Black BUY (TP: RM4.
M&A Securities Result Review (3Q16) PP14767/09/2012(030761) Cahya Mata Sarawak Berhad Thursday, Dec 1, 2016 BUY (TP: RM4.66) Loss-Making Business Turns Into Black Result Review Actual vs. expectation.
More informationMarket Access. Results Review (2Q15) M&A Securities. Genting Plantations Berhad. Hit by Plantation-Malaysia Segment. Wednesday, August 26, 2015
M&A Securities Results Review (2Q15) PP14767/09/2012(030761) Genting Plantations Berhad Wednesday, August 26, 2015 HOLD (TP: RM9.66) Hit by Plantation-Malaysia Segment Results Review Actual vs. expectations.
More informationMarket Access. Company Update. M&A Securities. Public Bank Berhad. Wednesday, April 27, BUY (Target Price: RM21.38) Proves to be Bellwether
M&A Securities Company Update PP14767/09/2012(030761) Public Bank Berhad Wednesday, April 27, 2016 BUY (Target Price: RM21.38) Proves to be Bellwether We recommend investors to accumulate Public Bank Bhd
More informationMarket Access. M&A Securities. Results Review (1Q15) TSH Resources Berhad HOLD (TP: RM2.38) A Tough Quarter - More Room to Grow.
M&A Securities Results Review (1Q15) PP14767/09/2012(030761) TSH Resources Berhad Thursday, May 21, 2015 HOLD (TP: RM2.38) A Tough Quarter - More Room to Grow Results Review Actual vs. expectations. TSH
More information